HROW
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Harrow, Inc. (HROW)Equibles does not estimate personal net worth.
Get an email with a short summary when Harrow, Inc. publishes a filing, an earnings call transcript or a press release.
Get HROW alertsMike Biega is recorded as Head of Investor Relations at Harrow, Inc. (HROW). Mike Biega has spoken on 3 earnings calls across 1 company, most recently for Harrow, Inc. on November 10, 2026. Harrow, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Harrow, Inc. includes Francis W. Mullery (CEO), Frank Mullery (CEO), John P. Saharek (CEO) and 7 others.
“The company's remarks may include forward-looking statements within the meaning of federal securities laws.”
“The company's remarks may include forward-looking statements within the meaning of federal securities laws.”
“The company's remarks may include forward-looking statements within the meaning of federal securities laws.”
HROW
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations